- Smith+Nephew (SNN, Financial) has launched the TRIGEN MAX Tibia Nailing System, offering side-specific nails for optimized treatment.
- The system aims to enhance surgery efficiency with innovative tools like a two-piece modular drop system and 5.0mm Lag Screws.
- Currently exclusive to the U.S., it builds on over two decades of TRIGEN technology excellence.
Smith+Nephew (SNN) has introduced its latest innovation in orthopedic trauma care with the launch of the TRIGEN MAX Tibia Nailing System. This system is particularly notable for being the first to offer side-specific nails designed to create anatomical screw trajectories. This development aims to optimize fragment fixation while minimizing soft tissue irritation, a significant advancement in treating tibial fractures.
The TRIGEN MAX system incorporates several design features intended to streamline surgical procedures and improve overall workflow efficiency. A key component is the two-piece modular drop system, which aids visualization and instrument usage during surgery. Additionally, the system includes a 12.5mm channel reamer to preserve the integrity of the entry point, and 5.0mm Lag Screws that allow for fracture compression in a single step.
Building upon more than 20 years of proven performance in the TRIGEN nail family, this new system represents a significant leap forward in trauma care. It specifically expands the range of treatable fracture types, including those previously challenging to address with intramedullary implants. The innovative system thus enhances Smith+Nephew's competitive position in the $2.7 billion global trauma fixation market.
Though currently available only in the United States, Smith+Nephew continues to demonstrate its commitment to advancing orthopedic solutions. The TRIGEN MAX Tibia Nailing System's introduction reiterates their strategic focus on expanding their Trauma & Extremities division within the highly competitive medical device sector.
